Pre-made Utomilumab benchmark antibody ( Whole mAb, anti-TNFRSF9/CD137 therapeutic antibody, Anti-ILA/4-1BB/CDw137 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-606

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-606 Category Tag

Product Details

Pre-Made Utomilumab biosimilar, Whole mAb, Anti-TNFRSF9/CD137 Antibody: Anti-ILA/4-1BB/CDw137 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Utomilumab is the proposed non-proprietary name for PF-05082566, an investigational immunotherapy and a fully human IgG2 agonist monoclonal antibody (mAb) that binds to the extracellular domain of human 4-1BB/CD137 with high affinity and specificity.

Products Name (INN Index)

Pre-Made Utomilumab biosimilar, Whole mAb, Anti-TNFRSF9/CD137 Antibody: Anti-ILA/4-1BB/CDw137 therapeutic antibody

INN Name

Utomilumab

Target

TNFRSF9

Format

Whole mAb

Derivation

Human

Species Reactivity

Human

CH1 Isotype

IgG2

VD LC

Lambda

Highest_Clin_Trial (Jan '20)

Phase-II

Est. Status

Active

100% SI Structure

6a3w:GH:DE:AB:JK/6mi2:DE:AB

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2016

Companies

Dana-Farber Cancer Institute,Immatics US,Kite Pharma,Kyowa Hakko Kirin,M. D. Anderson Cancer Center,Pfizer

Conditions Approved

NA

Conditions Active

Breast cancer,Oropharyngeal cancer,Solid tumours,B-cell lymphoma,Diffuse large B cell lymphoma,Follicular lymphoma,Ovarian cancer

Conditions Discontinued

Non-Hodgkin's lymphoma,Colorectal cancer

Development Tech

MorphoSys HuCAL Phage Display

Previous Name

NA

Gm Offical Target Name

TNFRSF9

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide